Home › Funds › Brighthouse › AVIP BlackRock Advantage Small Cap Growth Portfolio
Fund family: Brighthouse · Filed by AUGUSTAR VARIABLE INSURANCE PRODUCTS FUND INC (CIK 315754) · SEC series S000007882
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,869 with, 2 against, 2,646 abstentions (not counted as with management); 9 items carried no recommendation; 19 split votes are in neither count. Shareholder proposals: 0 FOR, 0 AGAINST, 17 abstained, by the filing’s own vote-source field.
The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Brighthouse | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 2.1% | 4,377 | 76.3% | 204,500 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 12.8% | 1,182 |
Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Brighthouse funds on 1,459 items (83.8% of the 1,741 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Brighthouse funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Atmus Filtration Technologies Inc. | 2026-05-12 | Advisory vote to approve the compensation of our named executive officers as disclosed in the proxy statement. | Abstain | FOR — 8 of 8 Brighthouse funds | Against | Passed (calculated), 98.2% support |
| Atmus Filtration Technologies Inc. | 2026-05-12 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026. | Abstain | FOR — 8 of 8 Brighthouse funds | Against | Approved, 100.0% support |
| Atmus Filtration Technologies Inc. | 2026-05-12 | Election of Directors: Diego Donoso | Abstain | FOR — 7 of 7 Brighthouse funds | Against | Elected, 98.0% support |
| Atmus Filtration Technologies Inc. | 2026-05-12 | Election of Directors: Heath Sharp | Abstain | FOR — 7 of 7 Brighthouse funds | Against | Elected, 99.1% support |
| Atmus Filtration Technologies Inc. | 2026-05-12 | Election of Directors: Stephanie J. Disher | Abstain | FOR — 7 of 7 Brighthouse funds | Against | Elected, 99.3% support |
| Atmus Filtration Technologies Inc. | 2026-05-12 | Election of Directors: Stuart A. Taylor II | Abstain | FOR — 7 of 7 Brighthouse funds | Against | Elected, 98.3% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Luc Seraphin | Abstain | FOR — 10 of 11 Brighthouse funds | Against | Passed (calculated), 98.5% support |
| Rambus Inc. | 2026-04-23 | Ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 10 of 11 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| IonQ, Inc. | 2026-06-16 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Approved, 99.3% support |
| Spyre Therapeutics, Inc. | 2026-05-27 | To approve the Company's amended and restated 2016 Employee Stock Purchase Plan. | Against | FOR — 6 of 6 Brighthouse funds | Against | — |
| Spyre Therapeutics, Inc. | 2026-05-27 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Approved, 92.9% support |
| Spyre Therapeutics, Inc. | 2026-05-27 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Approved, 100.0% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Approved, 99.3% support |
| SiteOne Landscape Supply, Inc. | 2026-05-13 | Advisory vote to approve Executive Compensation. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Approved, 97.9% support |
| SiteOne Landscape Supply, Inc. | 2026-05-13 | Ratification of the selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending January 3, 2027. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Approved, 99.7% support |
| Workiva Inc. | 2026-05-28 | Approval, on an advisory basis, of the compensation of Workiva's named executive officers. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Approved, 69.8% support |
| Workiva Inc. | 2026-05-28 | Election of Directors: Julie Iskow | Withhold | FOR — 6 of 6 Brighthouse funds | Against | Passed (calculated), 72.4% support |
| Workiva Inc. | 2026-05-28 | Election of Directors: R. Scott Herren | Withhold | FOR — 6 of 6 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| Garrett Motion Inc. | 2026-05-28 | The ratification of the appointment of Deloitte SA as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Passed (calculated), 99.3% support |
| Vistance Networks, Inc. | 2026-05-07 | Non-binding, advisory vote to approve the compensation of our named executive officers as described in the proxy statement. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Passed (calculated), 99.1% support |
| Vistance Networks, Inc. | 2026-05-07 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. | Abstain | FOR — 6 of 6 Brighthouse funds | Against | Passed (calculated), 99.0% support |
| Coeur Mining, Inc. | 2026-05-12 | Advisory resolution to approve named executive officer compensation. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 98.2% support |
| Coeur Mining, Inc. | 2026-05-12 | Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for 2026. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 99.7% support |
| Life Time Group Holdings, Inc. | 2026-04-22 | To approve, by a non-binding vote, the named executive officer compensation as disclosed in the proxy statement. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 95.3% support |
| Life Time Group Holdings, Inc. | 2026-04-22 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 98.7% support |
| Company | Meeting | Item | This fund | Most Brighthouse funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 2026-06-10 | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 99.9% support |
| Axsome Therapeutics, Inc. | 2026-06-05 | To approve, by non-binding advisory vote, the compensation of our named executive officers. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 98.0% support |
| Axsome Therapeutics, Inc. | 2026-06-05 | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 100.0% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 96.0% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 100.0% support |
| Travere Therapeutics Inc. | 2026-05-19 | To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 96.3% support |
| Travere Therapeutics Inc. | 2026-05-19 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 97.3% support |
| Travere Therapeutics Inc. | 2026-05-19 | To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 99.9% support |
| Garrett Motion Inc. | 2026-05-28 | The election to the Company's board of directors of the eight nominees named in the Proxy Statement: D'aun Norman | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 98.3% support |
| Garrett Motion Inc. | 2026-05-28 | The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Daniel Ninivaggi | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 97.9% support |
| Garrett Motion Inc. | 2026-05-28 | The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Joachim Drees | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 99.5% support |
| Garrett Motion Inc. | 2026-05-28 | The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Julia Steyn | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| Garrett Motion Inc. | 2026-05-28 | The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Olivier Rabiller | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 99.5% support |
| Garrett Motion Inc. | 2026-05-28 | The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Steven Tesoriere | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 99.5% support |
| Ambarella, Inc. | 2026-06-26 | To approve on a non-binding, advisory basis, the compensation of our named executive officers. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | — |
| Ambarella, Inc. | 2026-06-26 | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | — |
| Blue Bird Corporation | 2026-03-11 | To ratify the appointment of the Company's independent registered public accounting firm for the 2026 fiscal year. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Approved, 99.4% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Ratification of the appointment of Deloitte LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Ivanhoe Electric Inc. | 2026-06-04 | To seek a non-binding, advisory vote on the approval of our executive compensation. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 98.6% support |
| Mativ Holdings, Inc. | 2026-04-30 | Non-Binding Advisory Vote to Approve Executive Compensation. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 97.3% support |
| Mativ Holdings, Inc. | 2026-04-30 | Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. | Abstain | FOR — 5 of 5 Brighthouse funds | Against | Passed (calculated), 99.4% support |
| HealthEquity, Inc. | 2026-06-25 | Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan. | Against | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 98.6% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 98.4% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 98.5% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 98.9% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 98.1% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Scott Cutler | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 99.5% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 98.9% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| HealthEquity, Inc. | 2026-06-25 | Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Gassen | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| HealthEquity, Inc. | 2026-06-25 | To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 96.9% support |
| HealthEquity, Inc. | 2026-06-25 | To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 97.6% support |
| HealthEquity, Inc. | 2026-06-25 | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 99.4% support |
| ESCO Technologies Inc. | 2026-01-30 | To approve, on an advisory basis, the compensation of the Company's executive officers | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Approved, 98.4% support |
| ESCO Technologies Inc. | 2026-01-30 | To ratify the appointment of the Company's independent registered public accounting firm for the 2026 fiscal year | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Approved, 99.9% support |
| Radnet, Inc. | 2026-06-02 | An advisory vote to approve the compensation of the Company's Named Executive Officers. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Approved, 94.0% support |
| Radnet, Inc. | 2026-06-02 | The approval of an amendment and restatement to the Company's Equity Incentive Plan. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Approved, 97.2% support |
| Radnet, Inc. | 2026-06-02 | The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Approved, 99.5% support |
| Modine Manufacturing Company | 2025-08-21 | Advisory approval of the Company's named executive officer compensation. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Approved, 96.7% support |
| Modine Manufacturing Company | 2025-08-21 | Election of Directors: Mr. Mark Bendza | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 99.0% support |
| Modine Manufacturing Company | 2025-08-21 | Election of Directors: Mr. Neil D. Brinker | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Passed (calculated), 98.3% support |
| Modine Manufacturing Company | 2025-08-21 | Ratification of the appointment of the Company's independent registered public accounting firm. | Abstain | FOR — 8 of 9 Brighthouse funds | Against | Approved, 99.7% support |
| Ensign Group, Inc. | 2026-05-13 | Approval, on an advisory basis, of our named executive officers compensation. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 94.6% support |
| Ensign Group, Inc. | 2026-05-13 | Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 97.7% support |
| Alkermes plc | 2026-05-20 | To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | — |
| Alkermes plc | 2026-05-20 | To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 98.7% support |
| Alkermes plc | 2026-05-20 | To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | — |
| Alkermes plc | 2026-05-20 | To renew Board authority to allot and issue shares under Irish law. | Against | FOR — 7 of 8 Brighthouse funds | Against | — |
| Alkermes plc | 2026-05-20 | To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. | Against | FOR — 7 of 8 Brighthouse funds | Against | — |
| Sterling Infrastructure, Inc. | 2026-05-07 | Election of Directors: David S. Schulz | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Sterling Infrastructure, Inc. | 2026-05-07 | Election of Directors: Joseph A. Cutillo | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.5% support |
| Sterling Infrastructure, Inc. | 2026-05-07 | Election of Directors: Julie A. Dill | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| Sterling Infrastructure, Inc. | 2026-05-07 | Election of Directors: Roger A. Cregg | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| Sterling Infrastructure, Inc. | 2026-05-07 | To approve, on an advisory basis, the compensation of our named executive officers. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 98.4% support |
| Sterling Infrastructure, Inc. | 2026-05-07 | To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2026. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 98.1% support |
| Installed Building Products, Inc. | 2026-05-19 | Approval, on an advisory basis, of the compensation of our named executive officers. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 97.3% support |
| Installed Building Products, Inc. | 2026-05-19 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 99.6% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Charles J. Dockendorff | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 97.1% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Christopher A. Simon | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Claire Pomeroy | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.3% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Diane M. Bryant | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.3% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Ellen M. Zane | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 98.2% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Lloyd E. Johnson | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 98.4% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Mark W. Kroll | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 97.5% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Michael J. Coyle | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| Haemonetics Corporation | 2025-07-24 | Election of Directors: Robert E. Abernathy | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 98.2% support |
| Haemonetics Corporation | 2025-07-24 | To Ratify The Appointment Of Ernst & Young Llp As Our Independent Registered Public Accounting Firm For The Fiscal Year Ending March 28, 2026. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 96.6% support |
| Haemonetics Corporation | 2025-07-24 | To approve, on an advisory basis, the compensation of our named executive officers. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 98.7% support |
| PTC Therapeutics, Inc. | 2026-06-02 | Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | — |
| PTC Therapeutics, Inc. | 2026-06-02 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | — |
| Hamilton Lane Incorporated | 2025-09-04 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2026. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 99.8% support |
| Novanta Inc. | 2026-05-28 | Approval, on an advisory (non-binding) basis, of the Company's executive compensation. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: Darlene J.S. Solomon, Ph.D. | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 98.2% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: Frank A. Wilson | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: Lonny J. Carpenter | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 97.7% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: Mary Katherine Ladone | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: Matthew T. Farrell | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: Matthijs Glastra | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 97.5% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: Maxine L. Mauricio | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: R. Matthew Johnson | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 98.3% support |
| Novanta Inc. | 2026-05-28 | Election of Directors: Election of Director: Thomas N. Secor | Withhold | FOR — 7 of 8 Brighthouse funds | Against | Passed (calculated), 98.6% support |
| Novanta Inc. | 2026-05-28 | To appoint Deloitte and Touche LLP as the Company's independent registered public accounting firm to serve until the 2027 annual meeting of shareholders. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 100.0% support |
| Oceaneering International, Inc. | 2026-05-15 | Advisory vote on a resolution to approve the compensation of our named executive officers. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 97.2% support |
| Oceaneering International, Inc. | 2026-05-15 | Proposal to ratify the appointment of Ernst & Young LLP as our independent auditors for the year ending December 31, 2026. | Abstain | FOR — 7 of 8 Brighthouse funds | Against | Approved, 97.7% support |
| Rambus Inc. | 2026-04-23 | Advisory vote to approve named executive officer compensation. | Abstain | FOR — 9 of 11 Brighthouse funds | Against | Passed (calculated), 97.4% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Meera Rao | Abstain | FOR — 9 of 11 Brighthouse funds | Against | Passed (calculated), 93.9% support |
| Rambus Inc. | 2026-04-23 | Election of Directors: Necip Sayiner | Abstain | FOR — 9 of 11 Brighthouse funds | Against | Passed (calculated), 93.5% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: Eduardo Luna | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 99.8% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: J. Kenneth Thompson | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 92.6% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: Jeane L. Hull | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 96.0% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: Linda L. Adamany | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 92.9% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: Marilyn Schonberner | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 99.8% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: Mitchell J. Krebs | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 92.7% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: Paramita Das | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 97.4% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: Patrick Godin | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 98.5% support |
| Coeur Mining, Inc. | 2026-05-12 | Election of nine directors: Pierre Beaudoin | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 98.6% support |
| ImmunityBio, Inc. | 2026-06-09 | To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.8% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 98.8% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio Souza | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 99.5% support |
| Ionis Pharmaceuticals, Inc. | 2026-06-04 | To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan. | Against | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.8% support |
| Ionis Pharmaceuticals, Inc. | 2026-06-04 | To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 77.0% support |
| Ionis Pharmaceuticals, Inc. | 2026-06-04 | To make an advisory vote on executive compensation. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 96.4% support |
| Ionis Pharmaceuticals, Inc. | 2026-06-04 | To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 97.4% support |
| VSE Corporation | 2026-05-07 | Approval of an amendment to the Company's Restated Certificate of Incorporation to authorize the issuance of blank check preferred stock. | Against | FOR — 4 of 4 Brighthouse funds | Against | Approved, 83.8% support |
| VSE Corporation | 2026-05-07 | Ratification of the appointment of Grant Thornton LLP as VSE's independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.9% support |
| iRhythm Holdings, Inc. | 2026-05-27 | To approve the adoption of the Amended and Restated Certificate of Incorporation of iRhythm Technologies, Inc. to remove the pass-through voting provision. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.9% support |
| iRhythm Holdings, Inc. | 2026-05-27 | To approve, on a non-binding advisory basis, the named executive officer compensation. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 98.4% support |
| iRhythm Holdings, Inc. | 2026-05-27 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.9% support |
| Tutor Perini Corporation | 2026-05-20 | Approve the compensation of the Company's named executive officers on an advisory (non-binding) basis. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 97.6% support |
| Tutor Perini Corporation | 2026-05-20 | Ratify the appointment of Deloitte & Touche LLP as independent auditor of the Company for the year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 98.0% support |
| Scorpio Tankers Inc. | 2026-05-27 | Election of Director: Antonino Mattarella | Withhold | FOR — 4 of 4 Brighthouse funds | Against | — |
| Scorpio Tankers Inc. | 2026-05-27 | Election of Director: Emanuele A. Lauro | Withhold | FOR — 4 of 4 Brighthouse funds | Against | — |
| Core Scientific, Inc. | 2026-05-12 | To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.9% support |
| ACADIA Pharmaceuticals Inc. | 2026-05-29 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| ACADIA Pharmaceuticals Inc. | 2026-05-29 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 98.7% support |
| ACADIA Pharmaceuticals Inc. | 2026-05-29 | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 97.9% support |
| Disc Medicine, Inc. | 2026-06-18 | To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 98.9% support |
| Disc Medicine, Inc. | 2026-06-18 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 100.0% support |
| American Eagle Outfitters, Inc. | 2026-06-26 | Approve an amendment and restatement of the Company's 2023 Stock Award and Incentive Plan to increase the number of authorized shares thereunder. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 96.5% support |
| American Eagle Outfitters, Inc. | 2026-06-26 | Election of Class I Director: Jay L. Schottenstein | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Elected, 86.9% support |
| American Eagle Outfitters, Inc. | 2026-06-26 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2027. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 94.3% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Approval of the OneSpaWorld Holdings Limited Amended and Restated 2019 Equity Incentive Plan. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 95.9% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Approval, by non-binding advisory vote, of the compensation of the company's named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 95.0% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Election of Directors: Adam Hasiba | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 97.1% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Election of Directors: Glenn J. Fusfield | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 90.8% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Election of Directors: Leonard Fluxman | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 94.5% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Election of Directors: Stephen W. Powell | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 96.6% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 99.4% support |
| Skyward Specialty Insurance Group, Inc. | 2026-05-05 | The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 93.5% support |
| Skyward Specialty Insurance Group, Inc. | 2026-05-05 | The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.2% support |
| Axcelis Technologies, Inc. | 2026-05-05 | Proposal to ratify independent public accounting firm. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| Axcelis Technologies, Inc. | 2026-05-05 | Say on Pay - An advisory vote on the approval of executive compensation. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: Gregory M. Bryant | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Elected, 99.4% support |
| Navitas Semiconductor Corporation | 2026-06-25 | The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.6% support |
| Biohaven Ltd. | 2026-04-28 | A non-binding advisory vote on the compensation of the Company's named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 95.4% support |
| Biohaven Ltd. | 2026-04-28 | Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.8% support |
| Energy Fuels Inc. | 2026-06-24 | Election of Directors: Barbara A. Filas | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 98.1% support |
| Energy Fuels Inc. | 2026-06-24 | Election of Directors: Benjamin Eshleman III | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 88.6% support |
| Energy Fuels Inc. | 2026-06-24 | Election of Directors: Bruce D. Hansen | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 97.1% support |
| Energy Fuels Inc. | 2026-06-24 | Election of Directors: Dennis L. Higgs | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 89.0% support |
| Energy Fuels Inc. | 2026-06-24 | Election of Directors: Jaqueline Herrera | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 98.4% support |
| Energy Fuels Inc. | 2026-06-24 | Election of Directors: Ross R. Bhappu | Withhold | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 99.2% support |
| Stoke Therapeutics, Inc | 2026-06-03 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Pursuit Attractions and Hospitality, Inc. | 2026-06-04 | Approve, on an advisory basis, the compensation of our named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 98.4% support |
| Pursuit Attractions and Hospitality, Inc. | 2026-06-04 | Ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.3% support |
| Adient plc | 2026-03-10 | To approve, on an advisory basis, our named executive officer compensation. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 94.1% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Advisory vote to approve the compensation of the Company's named executive officers as disclosed in the 2026 Proxy Statement. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 98.0% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Ratification of the appointment of Plante & Moran, PLLC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 98.5% support |
| Vistance Networks, Inc. | 2026-05-07 | Non-binding, advisory vote to approve the frequency of future advisory votes on compensation of our named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Hirofumi Katase | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Patrick Loftus-Hills | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Robert Friedland | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 98.0% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Ronald Vance | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 99.3% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Russell Ball | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 97.4% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Taylor Melvin | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| Ivanhoe Electric Inc. | 2026-06-04 | Election of Directors: Victoire de Margerie | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| First Financial Corporation | 2026-04-15 | Approve, by non-binding vote, compensation paid to the Corporation's named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| First Financial Corporation | 2026-04-15 | Ratification of the appointment of Crowe LLP as the independent registered public accounting firm for the Corporation for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| Corvus Pharmaceuticals, Inc. | 2026-06-11 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 96.8% support |
| Corvus Pharmaceuticals, Inc. | 2026-06-11 | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.9% support |
| SmartFinancial, Inc. | 2026-05-21 | To approve, on a non-binding advisory basis, the compensation of SmartFinancial's named executive officers as listed in these proxy materials. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 97.1% support |
| SmartFinancial, Inc. | 2026-05-21 | To ratify the appointment of Elliott Davis, PLLC as the company's independent registered public accountants for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 100.0% support |
| ProPetro Holding Corp. | 2026-05-19 | Approval, on an advisory basis, of the compensation of our named executive officers | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 98.6% support |
| ProPetro Holding Corp. | 2026-05-19 | Ratification of the appointment of RSM US LLP as our independent, registered public accounting firm for the fiscal year ending December 31, 2026 | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| WAVE Life Sciences Ltd. | 2025-08-05 | To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 99.6% support |
| WAVE Life Sciences Ltd. | 2025-08-05 | To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| NetGear, Inc. | 2026-05-28 | Proposal to approve, on a non-binding advisory basis, a resolution approving the compensation of our Named Executive Officers in the Proxy Statement. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 97.9% support |
| NetGear, Inc. | 2026-05-28 | Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Passed (calculated), 97.9% support |
| Akero Therapeutics, Inc. | 2025-12-02 | To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the adoption of the Merger Agreement at the time of the special meeting. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| Akero Therapeutics, Inc. | 2025-12-02 | To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | Approved, 98.0% support |
| Omada Health, Inc. | 2026-06-16 | The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 4 of 4 Brighthouse funds | Against | — |
| Watts Water Technologies, Inc. | 2026-05-19 | Advisory vote to approve named executive officer compensation. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 98.3% support |
| Watts Water Technologies, Inc. | 2026-05-19 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 97.0% support |
| Pool Corporation | 2026-04-29 | Ratification of the retention of Ernst & Young LLP, certified public accountants, as our independent registered public accounting firm for the 2026 fiscal year. | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Approved, 96.5% support |
| Pool Corporation | 2026-04-29 | Say-on-pay vote: Advisory vote to approve the compensation of our named executive officers as disclosed in the proxy statement. | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Approved, 94.9% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: Anne T. DelSanto | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 98.5% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: Brian M. Shirley | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 99.7% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: David W. Reed | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 99.7% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: Frederick A. Ball | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 97.6% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: Grant H. Beard | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 98.3% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: John A. Roush | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 96.5% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: Lanesha T. Minnix | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 98.3% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: Ronald C. Foster | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 98.0% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: Stephen D. Kelley | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 98.6% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Election of ten (10) directors: Tina M. Donikowski | Withhold | FOR — 8 of 10 Brighthouse funds | Against | Elected, 97.6% support |
| InterDigital, Inc. | 2026-06-10 | Advisory resolution to approve executive compensation. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 98.5% support |
| InterDigital, Inc. | 2026-06-10 | Approval of bylaws amendment to allow for officer exculpation as permitted by Pennsylvania law. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 93.0% support |
| InterDigital, Inc. | 2026-06-10 | Election of Directors: Derek K. Aberle | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 99.8% support |
| InterDigital, Inc. | 2026-06-10 | Election of Directors: Jean F. Rankin | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 97.6% support |
| InterDigital, Inc. | 2026-06-10 | Election of Directors: Joan H. Gillman | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 97.4% support |
| InterDigital, Inc. | 2026-06-10 | Election of Directors: John A. Kritzmacher | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 96.8% support |
| InterDigital, Inc. | 2026-06-10 | Election of Directors: John D. Markley, Jr. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 91.5% support |
| InterDigital, Inc. | 2026-06-10 | Election of Directors: Lawrence (Liren) Chen | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 99.6% support |
| InterDigital, Inc. | 2026-06-10 | Election of Directors: S. Douglas Hutcheson | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 98.5% support |
| InterDigital, Inc. | 2026-06-10 | Election of Directors: Samir Armaly | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 98.4% support |
| InterDigital, Inc. | 2026-06-10 | Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm of InterDigital, Inc. for the year ending December 31, 2026. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 98.3% support |
| Lantheus Holdings, Inc. | 2026-04-30 | The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 99.6% support |
| Commvault Systems, Inc. | 2025-08-07 | To approve additional shares to be available for grant under Commvault's 2016 Omnibus Incentive Plan. | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 95.4% support |
| Commvault Systems, Inc. | 2025-08-07 | To approve, on an advisory basis, Commvault's executive compensation. | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 96.2% support |
| Commvault Systems, Inc. | 2025-08-07 | To ratify the appointment of Ernst & Young LLP as Commvault's independent public accountants for the fiscal year ending March 31, 2026. | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 94.4% support |
| Commvault Systems, Inc. | 2025-08-07 | To re-elect the Directors for a one-year term: Allison Pickens | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 99.0% support |
| Commvault Systems, Inc. | 2025-08-07 | To re-elect the Directors for a one-year term: Arlen Shenkman | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Commvault Systems, Inc. | 2025-08-07 | To re-elect the Directors for a one-year term: Chuck Moran | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Commvault Systems, Inc. | 2025-08-07 | To re-elect the Directors for a one-year term: Keith Geeslin | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Commvault Systems, Inc. | 2025-08-07 | To re-elect the Directors for a one-year term: Martha Bejar | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 98.2% support |
| Commvault Systems, Inc. | 2025-08-07 | To re-elect the Directors for a one-year term: Nicola Adamo | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 99.1% support |
| Commvault Systems, Inc. | 2025-08-07 | To re-elect the Directors for a one-year term: Sanjay Mirchandani | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Commvault Systems, Inc. | 2025-08-07 | To re-elect the Directors for a one-year term: Shane Sanders | Abstain | FOR — 8 of 10 Brighthouse funds | Against | Passed (calculated), 98.3% support |
| Weatherford International plc | 2026-06-11 | Election of Directors: Benjamin C. Duster, IV | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 88.5% support |
| Weatherford International plc | 2026-06-11 | Election of Directors: Charles M. Sledge | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 96.5% support |
| Weatherford International plc | 2026-06-11 | Election of Directors: Girishchandra K. Saligram | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Weatherford International plc | 2026-06-11 | Election of Directors: Jacqueline C. Mutschler | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 88.5% support |
| Weatherford International plc | 2026-06-11 | Election of Directors: Neal P. Goldman | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 81.9% support |
| Weatherford International plc | 2026-06-11 | Election of Directors: Steven Beringhause | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| Weatherford International plc | 2026-06-11 | To approve a renewal of the Board's annual authority to issue shares under Irish law. | Against | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| Weatherford International plc | 2026-06-11 | To approve a renewal of the Board's annual power to opt-out of statutory preemption rights under Irish law. | Against | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 99.4% support |
| Weatherford International plc | 2026-06-11 | To approve the amendment and restatement of the Weatherford International plc Fourth Amended and Restated 2019 Equity Incentive Plan. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | — |
| Weatherford International plc | 2026-06-11 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 99.2% support |
| Weatherford International plc | 2026-06-11 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm and auditor for the fiscal year ending December 31, 2026 and KPMG Chartered Accountants, Dublin, as our statutory auditor under Irish law to hold office until the close of the 2027 AGM, and to authorize our Bo | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Passed (calculated), 99.3% support |
| Option Care Health, Inc. | 2026-05-20 | To approve, on a non-binding advisory basis, our executive compensation. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 97.1% support |
| Option Care Health, Inc. | 2026-05-20 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 99.2% support |
| UFP Industries, Inc. | 2026-04-22 | To approve, on an advisory (non-binding) basis, the compensation paid to our Named Executives. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 96.4% support |
| UFP Industries, Inc. | 2026-04-22 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal 2026. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 99.6% support |
| The Vita Coco Company, Inc. | 2026-06-03 | Advisory vote on executive compensation. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 95.4% support |
| Oceaneering International, Inc. | 2026-05-15 | Election of Class I Directors: William B. Berry | Withhold | FOR — 6 of 7 Brighthouse funds | Against | Elected, 96.9% support |
| Knife River Corporation | 2026-05-20 | Advisory Vote to Approve the Compensation Paid to the Company's Named Executive Officers. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 96.2% support |
| Knife River Corporation | 2026-05-20 | Election of Two Class III Directors: Brian R. Gray | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 99.9% support |
| Knife River Corporation | 2026-05-20 | Election of Two Class III Directors: Karen B. Fagg | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Elected, 95.2% support |
| Knife River Corporation | 2026-05-20 | Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026. | Abstain | FOR — 6 of 7 Brighthouse funds | Against | Approved, 96.6% support |
| Stride, Inc. | 2025-12-04 | Approval of the Company's 2025 Employee Stock Purchase Plan; and | Against | FOR — 6 of 7 Brighthouse funds | Against | — |
| Stride, Inc. | 2025-12-04 | Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: James J. Rhyu | Withhold | FOR — 6 of 7 Brighthouse funds | Against | Elected, 94.0% support |
| Kymera Therapeutics, Inc. | 2026-06-24 | To approve, on a non-binding advisory basis, the compensation of our named executive officers; and | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Approved, 96.8% support |
| Kymera Therapeutics, Inc. | 2026-06-24 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Approved, 100.0% support |
| Pool Corporation | 2026-04-29 | Election of Directors: David G. Whalen | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Elected, 87.4% support |
| Pool Corporation | 2026-04-29 | Election of Directors: Debra S. Oler | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Elected, 99.5% support |
| Pool Corporation | 2026-04-29 | Election of Directors: John E. Stokely | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Elected, 96.3% support |
| Pool Corporation | 2026-04-29 | Election of Directors: Kevin M. Murphy | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Elected, 99.4% support |
| Pool Corporation | 2026-04-29 | Election of Directors: Manuel J. Perez de la Mesa | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Elected, 99.0% support |
| Pool Corporation | 2026-04-29 | Election of Directors: Mark A. Pompa | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Elected, 99.3% support |
| Pool Corporation | 2026-04-29 | Election of Directors: Peter D. Arvan | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Elected, 99.1% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Patrick M. Dewar | Withhold | FOR — 7 of 9 Brighthouse funds | Against | Elected, 96.4% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Vinod M. Khilnani | Withhold | FOR — 7 of 9 Brighthouse funds | Against | Elected, 96.6% support |
| Modine Manufacturing Company | 2025-08-21 | Election of Directors: Mr. David J. Wilson | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Passed (calculated), 91.6% support |
| Modine Manufacturing Company | 2025-08-21 | Election of Directors: Ms. Katherine C. Harper | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Passed (calculated), 95.5% support |
| Nuvalent, Inc. | 2026-06-16 | To approve, on an advisory basis, the compensation paid to our named executive officers. | Abstain | FOR — 7 of 9 Brighthouse funds | Against | Approved, 97.5% support |
| Nextracker Inc. | 2025-08-18 | The approval, on an advisory basis, of the compensation of our named executive officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 80.4% support |
| Tetra Tech, Inc. | 2026-02-19 | Election of Directors: Dan L. Batrack | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 95.9% support |
| Tetra Tech, Inc. | 2026-02-19 | Election of Directors: Gary R. Birkenbeuel | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 96.7% support |
| Tetra Tech, Inc. | 2026-02-19 | Election of Directors: Jeffrey R. Feeler | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Tetra Tech, Inc. | 2026-02-19 | Election of Directors: Kirsten M. Volpi | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 92.9% support |
| Tetra Tech, Inc. | 2026-02-19 | Election of Directors: M. Susan Hardwick | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 98.2% support |
| Tetra Tech, Inc. | 2026-02-19 | Election of Directors: Prashant Gandhi | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 87.2% support |
| Tetra Tech, Inc. | 2026-02-19 | To approve the Amendment to the Employee Stock Purchase Plan. | Against | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.5% support |
| Tetra Tech, Inc. | 2026-02-19 | To approve, on an advisory basis, the Company's named executive officers' compensation. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 92.7% support |
| Tetra Tech, Inc. | 2026-02-19 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 91.5% support |
| Oscar Health, Inc. | 2026-06-04 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 99.9% support |
| Hecla Mining Company | 2026-05-21 | Advisory resolution to approve our named executive officer compensation for 2025. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 95.5% support |
| Hecla Mining Company | 2026-05-21 | Proposal to ratify and approve the selection of BDO USA, P.C., as our independent registered public accounting firm for the calendar year ending December 31, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 91.9% support |
| Old National Bancorp | 2026-05-13 | Approval of a non-binding advisory proposal on the compensation of the Company's named executive officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 97.0% support |
| Old National Bancorp | 2026-05-13 | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.8% support |
| Henry Schein, Inc. | 2026-05-21 | Shareholder Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 57.6% support |
| Henry Schein, Inc. | 2026-05-21 | Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 98.0% support |
| Henry Schein, Inc. | 2026-05-21 | Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 98.3% support |
| ImmunityBio, Inc. | 2026-06-09 | Election of Directors: Barry J. Simon, M.D. | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.7% support |
| ImmunityBio, Inc. | 2026-06-09 | Election of Directors: Bruce Wendel | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.8% support |
| ImmunityBio, Inc. | 2026-06-09 | Election of Directors: Cheryl L. Cohen | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.7% support |
| ImmunityBio, Inc. | 2026-06-09 | Election of Directors: Richard Adcock | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.8% support |
| ImmunityBio, Inc. | 2026-06-09 | Election of Directors: Wesley Clark | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.4% support |
| Caris Life Sciences, Inc. | 2026-06-04 | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 100.0% support |
| Sanmina Corporation | 2026-03-09 | To ratify the appointment of PricewaterhouseCoopers LLP as Sanmina Corporation's independent registered public accounting firm for the fiscal year ending October 3, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 98.9% support |
| Federal Signal Corporation | 2026-04-21 | Approve, on an advisory basis, the compensation of our named executive officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 92.3% support |
| Federal Signal Corporation | 2026-04-21 | Ratify the appointment of Deloitte & Touche LLP as Federal Signal Corporation's independent registered public accounting firm for fiscal year 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.3% support |
| StoneX Group Inc. | 2026-03-10 | To approve the advisory (non-binding) resolution relating to executive compensation. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 89.6% support |
| StoneX Group Inc. | 2026-03-10 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the 2026 fiscal year. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.5% support |
| Vicor Corporation | 2026-06-19 | Advisory vote to approve the compensation of the Corporation's named executive officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Fluor Corporation | 2026-05-06 | An advisory vote to approve the company's executive compensation. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 87.5% support |
| Fluor Corporation | 2026-05-06 | The ratification of the appointment by our Audit Committee of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 97.5% support |
| IES Holdings, Inc. | 2026-02-19 | Advisory Vote To Approve Named Executive Officer Compensation. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 92.8% support |
| IES Holdings, Inc. | 2026-02-19 | Ratification Of Appointment Of Ernst & Young Llp As Auditors For The Company For Fiscal Year 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 99.4% support |
| Dycom Industries, Inc. | 2026-05-28 | Election of Directors: Philip R. Gallagher | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| Dycom Industries, Inc. | 2026-05-28 | Election of Directors: Raejeanne Skillern | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Dycom Industries, Inc. | 2026-05-28 | Election of Directors: Stephen O. LeClair | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| Dycom Industries, Inc. | 2026-05-28 | To approve, by non-binding advisory vote, executive compensation. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 97.0% support |
| Dycom Industries, Inc. | 2026-05-28 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal 2027. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| Hims & Hers Health, Inc. | 2026-06-11 | Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | To approve a non-binding advisory proposal regarding named executive officer compensation. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 98.2% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending January 30, 2027. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.4% support |
| Joby Aviation, Inc. | 2026-06-02 | Approval, in a non-binding advisory vote, of the compensation of Joby's named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 98.6% support |
| Joby Aviation, Inc. | 2026-06-02 | Ratify the appointment of PricewaterhouseCoopers LLP as Joby's independent registered public accounting firm for fiscal year 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.5% support |
| Cogent Biosciences, Inc. | 2026-06-09 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 90.2% support |
| Cogent Biosciences, Inc. | 2026-06-09 | Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| TeraWulf Inc. | 2026-06-09 | The ratification of the appointment of Deloitte & Touche LLP as the Company's Independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 99.8% support |
| Herc Holdings Inc. | 2026-05-14 | Approval, by a non-binding advisory vote, of the named executive officers' compensation. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 97.7% support |
| Herc Holdings Inc. | 2026-05-14 | Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: John A. Olin | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Herc Holdings Inc. | 2026-05-14 | Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Lawrence H. Silber | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Herc Holdings Inc. | 2026-05-14 | Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Patrick S. Shannon | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Herc Holdings Inc. | 2026-05-14 | Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Shari L. Burgess | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Herc Holdings Inc. | 2026-05-14 | Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 99.8% support |
| Impinj, Inc. | 2026-05-28 | To approve, on an advisory basis, the compensation of our named executive officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 96.0% support |
| Impinj, Inc. | 2026-05-28 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.9% support |
| Travere Therapeutics Inc. | 2026-05-19 | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | — |
| Badger Meter, Inc. | 2026-04-24 | Advisory Vote To Approve Compensation Of Our Named Executive Officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | — |
| Badger Meter, Inc. | 2026-04-24 | Ratification Of The Appointment Of Ernst & Young Llp As Independent Registered Public Accountants For 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | — |
| The Brink's Company | 2026-04-28 | Approval of a non-binding advisory resolution on named executive officer compensation. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 98.8% support |
| The Brink's Company | 2026-04-28 | Approval of the Company's amended and restated 2024 Equity Incentive Plan. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 97.2% support |
| The Brink's Company | 2026-04-28 | Election of Directors: A. Louis Parker | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 98.3% support |
| The Brink's Company | 2026-04-28 | Election of Directors: Ian D. Clough | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 98.7% support |
| The Brink's Company | 2026-04-28 | Election of Directors: Kathie J. Andrade | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 93.7% support |
| The Brink's Company | 2026-04-28 | Election of Directors: Keith R. Wyche | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 98.3% support |
| The Brink's Company | 2026-04-28 | Election of Directors: Mark Eubanks | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 98.9% support |
| The Brink's Company | 2026-04-28 | Election of Directors: Michael J. Herling | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 97.3% support |
| The Brink's Company | 2026-04-28 | Election of Directors: Paul G. Boynton | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 98.0% support |
| The Brink's Company | 2026-04-28 | Election of Directors: Susan E. Docherty | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 98.1% support |
| The Brink's Company | 2026-04-28 | Election of Directors: Timothy J. Tynan | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.3% support |
| The Brink's Company | 2026-04-28 | Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.8% support |
| Iridium Communications Inc. | 2026-05-20 | Advisory vote to approve the compensation of Iridium Communications Inc.'s named executive officers | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 86.8% support |
| Iridium Communications Inc. | 2026-05-20 | Approval of the Iridium Communications Inc. Amended and Restated 2015 Equity Incentive Plan | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 90.9% support |
| Iridium Communications Inc. | 2026-05-20 | Ratification of the selection of KPMG LLP as Iridium Communications Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026 | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 99.9% support |
| Construction Partners, Inc. | 2026-03-24 | Proposal to ratify the appointment of RSM US LLP as the Company's independent registered public accountants for the fiscal year ending September 30, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Enova International, Inc. | 2026-05-13 | A non-binding advisory vote to approve the compensation paid to the Company's named executive officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 95.5% support |
| Enova International, Inc. | 2026-05-13 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Dale Anne Reiss | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.4% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Dennis D. Oklak | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.1% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Gary G. Smalley | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.9% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Jigisha Desai | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 90.6% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Peter Arkley | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.8% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Raymond R. Oneglia | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 95.9% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Robert C. Lieber | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.1% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Ronald N. Tutor | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.7% support |
| Tutor Perini Corporation | 2026-05-20 | Election of Directors: Sidney J. Feltenstein | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.3% support |
| Korn Ferry | 2025-09-18 | Election of Directors: Angel R. Martinez | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Korn Ferry | 2025-09-18 | Election of Directors: Gary D. Burnison | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| Korn Ferry | 2025-09-18 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's 2026 fiscal year. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 96.9% support |
| Applied Optoelectronics, Inc. | 2026-06-04 | To approve an adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, one or more of the other proposals to be voted on at the Annu | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 93.9% support |
| Applied Optoelectronics, Inc. | 2026-06-04 | To approve the amendment of our Amended and Restated Certificate of Incorporation, as amended, to clarify the voting standard that applies to certain future amendments. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.2% support |
| Applied Optoelectronics, Inc. | 2026-06-04 | To approve, on an advisory basis, the compensation of our named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 98.3% support |
| Liquidia Corporation | 2026-06-16 | Election of Directors: David Johnson | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Liquidia Corporation | 2026-06-16 | To approve, on an advisory basis, the compensation of our named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | — |
| Liquidia Corporation | 2026-06-16 | To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| Magnite, Inc. | 2026-06-08 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 89.2% support |
| Magnite, Inc. | 2026-06-08 | Election of Class III Directors: David Pearson | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 95.3% support |
| Magnite, Inc. | 2026-06-08 | Election of Class III Directors: Doug Knopper | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 92.8% support |
| Magnite, Inc. | 2026-06-08 | Election of Class III Directors: Paul Caine | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 95.0% support |
| Magnite, Inc. | 2026-06-08 | Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the current fiscal year. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 99.8% support |
| Solaris Energy Infrastructure, Inc. | 2026-05-15 | Ratify the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.6% support |
| MYR Group Inc. | 2026-04-23 | Advisory Approval Of The Compensation Of Our Named Executive Officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 97.8% support |
| MYR Group Inc. | 2026-04-23 | Ratification Of The Appointment Of Our Independent Registered Public Accounting Firm. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.4% support |
| Patterson-UTI Energy, Inc. | 2026-06-04 | Approval of the amendment to Patterson-UTI's 2021 Long-Term Incentive Plan. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 97.7% support |
| Patterson-UTI Energy, Inc. | 2026-06-04 | Approval, on an advisory basis, of Patterson-UTI's compensation of its named executive officers. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 95.2% support |
| Patterson-UTI Energy, Inc. | 2026-06-04 | Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Patterson-UTI for the fiscal year ending December 31, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 97.0% support |
| Core Scientific, Inc. | 2026-05-12 | Election of Directors: Adam Sullivan | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.9% support |
| Core Scientific, Inc. | 2026-05-12 | Election of Directors: Elizabeth Crain | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.7% support |
| Nicolet Bankshares, Inc. | 2026-01-26 | Adjournment. A proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies to approve the merger agreement and the transactions contemplated by the merger agreement. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 98.3% support |
| Nicolet Bankshares, Inc. | 2026-05-18 | Ratification of the selection of Forvis Mazars, LLP as Nicolet's Independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.8% support |
| Tidewater Inc. | 2026-06-16 | Approve the First Amendment to the Company's Amended and Restated 2021 Stock Incentive Plan to increase the maximum number of shares of common stock available for issuance by 2,250,000. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 95.3% support |
| Tidewater Inc. | 2026-06-16 | Election of Directors - To elect seven (7) directors each for a one-year term: Dick H. Fagerstal | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Elected, 96.6% support |
| Tidewater Inc. | 2026-06-16 | Election of Directors - To elect seven (7) directors each for a one-year term: Kenneth H. Traub | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Elected, 94.8% support |
| Tidewater Inc. | 2026-06-16 | Election of Directors - To elect seven (7) directors each for a one-year term: Lois K. Zabrocky | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Elected, 99.8% support |
| Tidewater Inc. | 2026-06-16 | Election of Directors - To elect seven (7) directors each for a one-year term: Louis A. Raspino | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Elected, 99.5% support |
| Tidewater Inc. | 2026-06-16 | Election of Directors - To elect seven (7) directors each for a one-year term: Melissa Cougle | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Elected, 99.8% support |
| Tidewater Inc. | 2026-06-16 | Election of Directors - To elect seven (7) directors each for a one-year term: Quintin V. Kneen | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Elected, 99.5% support |
| Tidewater Inc. | 2026-06-16 | Election of Directors - To elect seven (7) directors each for a one-year term: Robert E. Robotti | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Elected, 97.7% support |
| Tidewater Inc. | 2026-06-16 | Say on Pay Vote - An advisory vote to approve executive compensation as disclosed in the proxy statement. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.1% support |
| Avista Corporation | 2026-05-14 | Advisory (non-binding) vote on executive compensation. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 96.5% support |
| Avista Corporation | 2026-05-14 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 96.8% support |
| M/I Homes, Inc. | 2026-05-13 | A non-binding, advisory resolution to approve the compensation of the named executive officers of M/I Homes, Inc. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 95.7% support |
| M/I Homes, Inc. | 2026-05-13 | To ratify the appointment of Deloitte & Touche LLP as M/I Homes, Inc.'s independent registered public accounting firm for the 2026 fiscal year. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 98.2% support |
| Tarsus Pharmaceuticals, Inc. | 2026-06-25 | To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Scott Morrison | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.4% support |
| Tarsus Pharmaceuticals, Inc. | 2026-06-25 | To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Wendy Yarno | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.9% support |
| Tarsus Pharmaceuticals, Inc. | 2026-06-25 | To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | — |
| Tarsus Pharmaceuticals, Inc. | 2026-06-25 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 100.0% support |
| Rigetti Computing, Inc. | 2026-06-09 | To ratify the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 99.2% support |
| Primoris Services Corporation | 2026-04-30 | To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Carla S. Mashinski | Withhold | FOR — 5 of 6 Brighthouse funds | Against | — |
| Primoris Services Corporation | 2026-04-30 | To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: David L. King | Withhold | FOR — 5 of 6 Brighthouse funds | Against | — |
| Primoris Services Corporation | 2026-04-30 | To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Harpreet Saluja | Withhold | FOR — 5 of 6 Brighthouse funds | Against | — |
| Primoris Services Corporation | 2026-04-30 | To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Jose R. Rodriguez | Withhold | FOR — 5 of 6 Brighthouse funds | Against | — |
| Primoris Services Corporation | 2026-04-30 | To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Koti Vadlamudi | Withhold | FOR — 5 of 6 Brighthouse funds | Against | — |
| Primoris Services Corporation | 2026-04-30 | To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Michael E. Ching | Withhold | FOR — 5 of 6 Brighthouse funds | Against | — |
| Primoris Services Corporation | 2026-04-30 | To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Patricia K. Wagner | Withhold | FOR — 5 of 6 Brighthouse funds | Against | — |
| Primoris Services Corporation | 2026-04-30 | To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Terry D. McCallister | Withhold | FOR — 5 of 6 Brighthouse funds | Against | — |
| Primoris Services Corporation | 2026-04-30 | To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.2% support |
| OSI Systems, Inc. | 2025-12-11 | Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Central Garden & Pet Company | 2026-02-11 | To approve an advisory vote on the compensation of the Company's named executive officers as described in the accompanying proxy statement. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 98.7% support |
| Central Garden & Pet Company | 2026-02-11 | To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending on September 26, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 98.7% support |
| Resideo Technologies, Inc. | 2026-06-03 | Advisory Vote to Approve Executive Compensation. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 96.8% support |
| Resideo Technologies, Inc. | 2026-06-03 | Ratification of the Appointment of Independent Registered Public Accounting Firm. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.8% support |
| Constellium SE | 2026-05-21 | Allocation of the results of the Company for the fiscal year ended December 31, 2025 | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Constellium SE | 2026-05-21 | Approval of the aggregate maximum amount of the directors' annual fixed fees | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Constellium SE | 2026-05-21 | Approval of the consolidated financial statements and transactions for the fiscal year ended December 31, 2025 | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Constellium SE | 2026-05-21 | Approval of the statutory financial statements and transactions for the fiscal year ended December 31, 2025 | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Constellium SE | 2026-05-21 | Approval, on an advisory (non-binding) basis, of the 2025 compensation of the Company's named executive officers | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 93.2% support |
| Constellium SE | 2026-05-21 | Discharge (quitus) of the directors, the Chief Executive Officer, and the Statutory Auditors of the Company in respect of the performance of their duties for the fiscal year ended December 31, 2025 | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 86.7% support |
| Constellium SE | 2026-05-21 | Powers to carry out formalities | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 100.0% support |
| Constellium SE | 2026-05-21 | Ratification of the interim appointment of Ms. Ingrid Joerg as a director | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 99.7% support |
| IMAX Corporation | 2026-06-10 | Appointment of Auditors Appointment of PricewaterhouseCoopers LLP as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration. | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Approved, 98.9% support |
| IMAX Corporation | 2026-06-10 | 10 wordings Election of Directors Election of the ten nominees for the Board of Directors: Gail Berman | Against | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 92.5% support |
| Xencor, Inc. | 2026-06-16 | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 96.6% support |
| Pediatrix Medical Group, Inc. | 2026-05-07 | Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan | Abstain | FOR — 3 of 3 Brighthouse funds | Against | — |
| Immunome, Inc. | 2026-06-09 | To approve, on an advisory basis, the compensation of our named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 98.4% support |
| Immunome, Inc. | 2026-06-09 | To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 100.0% support |
| Ducommun Incorporated | 2026-04-29 | Advisory resolution to approve executive compensation. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 94.3% support |
| Ducommun Incorporated | 2026-04-29 | Approval of Amendment and Restatement of the Company's 2024 Stock Incentive Plan. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 96.7% support |
| Ducommun Incorporated | 2026-04-29 | Ratification of the selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 95.0% support |
| Dorian LPG Ltd. | 2025-09-05 | Approval, on an advisory, non-binding basis, of the compensation of our named executive officers, as disclosed in this proxy statement. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 87.5% support |
| Dorian LPG Ltd. | 2025-09-05 | Election of Directors: John C. Hadjipateras | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.2% support |
| Dorian LPG Ltd. | 2025-09-05 | Election of Directors: Malcolm McAvity | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 93.0% support |
| Dorian LPG Ltd. | 2025-09-05 | Election of Directors: Mark Ross | Withhold | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.4% support |
| Dorian LPG Ltd. | 2025-09-05 | Ratification of the appointment of Deloitte Certified Public Accountants S.A. as the Company's independent auditors for the fiscal year ending March 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 98.9% support |
| BioCryst Pharmaceuticals, Inc. | 2026-06-11 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 96.7% support |
| GeneDx Holdings Corp. | 2026-06-18 | Approval, on a non-binding advisory basis, the compensation of our named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 93.9% support |
| GeneDx Holdings Corp. | 2026-06-18 | Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.4% support |
| NuScale Power Corporation | 2025-12-16 | A proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if a quorum is not present or there are insufficient votes at the time of the Special Meeting to approve the Authorized Share Increase Amendment. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | — |
| Healthcare Services Group, Inc. | 2026-05-26 | To approve an amendment to the Company's 2020 Amended Omnibus Incentive Plan to increase the number of shares of our common stock authorized for issuance by 2,500,000 shares. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 95.6% support |
| Healthcare Services Group, Inc. | 2026-05-26 | To approve and ratify Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 98.1% support |
| Healthcare Services Group, Inc. | 2026-05-26 | To consider an advisory vote on a non-binding resolution to approve the compensation of our named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.9% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: A. Clayton Perfall | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.4% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Angela S. Lalor | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.0% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Barbara W. Bodem | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.6% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Brady Shirley | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.5% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Christine Ortiz | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.6% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Damien McDonald | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.9% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Liam J. Kelly | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.6% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Philip A. Okala | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.6% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Rajiv Vinnakota | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.9% support |
| Enovis Corporation | 2026-05-19 | Election of Directors: Sharon Wienbar | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.6% support |
| Enovis Corporation | 2026-05-19 | To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 97.5% support |
| Enovis Corporation | 2026-05-19 | To approve on an advisory basis the compensation of our named executive officers. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 95.8% support |
| Enovis Corporation | 2026-05-19 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 98.3% support |
| A10 Networks, Inc. | 2026-04-22 | To ratify the appointment of Grant Thornton LLP as our independent public accounting firm for our fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| NovoCure Limited | 2026-06-03 | A non-binding advisory vote to approve executive compensation. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 91.0% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: Allyson Ocean | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.0% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: Asaf Danziger | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.3% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: David Hung | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.5% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: Frank Leonard | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.6% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: Jeryl Hilleman | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.4% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: Kinyip Gabriel Leung | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 95.9% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: Kristin Stafford | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.5% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: Martin Madden | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.2% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: Timothy Scannell | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.4% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: William Doyle | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 96.8% support |
| NovoCure Limited | 2026-06-03 | Election of Directors: William Vernon | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.2% support |
| NovoCure Limited | 2026-06-03 | The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 202 | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Approved, 97.5% support |
| Proto Labs, Inc. | 2026-05-19 | Advisory vote on executive compensation. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 82.3% support |
| Proto Labs, Inc. | 2026-05-19 | Approval of the amendment to the Amended and Restated Proto Labs, Inc. 2022 Long-Term Incentive Plan. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.6% support |
| Proto Labs, Inc. | 2026-05-19 | Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.9% support |
| Stewart Information Services Corporation | 2026-05-07 | Approval of the compensation of Stewart Information Services Corporation's named executive officers (Say-on-Pay). | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 98.5% support |
| Stewart Information Services Corporation | 2026-05-07 | Ratification of the appointment of KPMG LLP as Stewart Information Services Corporation's independent auditors for 2026. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Approved, 99.1% support |
| Turning Point Brands, Inc. | 2026-05-04 | Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.2% support |
| Turning Point Brands, Inc. | 2026-05-04 | To approve, on an advisory basis, named executive officer compensation. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.8% support |
| Adient plc | 2026-03-10 | Election of Directors: Barb J. Samardzich | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.1% support |
| Adient plc | 2026-03-10 | Election of Directors: Frederick A. Henderson | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.9% support |
| Adient plc | 2026-03-10 | Election of Directors: Jerome J. Dorlack | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.7% support |
| Adient plc | 2026-03-10 | Election of Directors: Jodi E. Eddy | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 99.2% support |
| Adient plc | 2026-03-10 | Election of Directors: Julie L. Bushman | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.2% support |
| Adient plc | 2026-03-10 | Election of Directors: Peter H. Carlin | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.2% support |
| Adient plc | 2026-03-10 | Election of Directors: Richard Goodman | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.2% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Carol G. Barton | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.5% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Francis X. McCahill, III | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.6% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Jon W. Springer | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.4% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Kimberly D. Campos | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.7% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Marlene M. Gordon | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.4% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Michael A. Pietrangelo | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.7% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Ozzie A. Schindler | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.9% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Richard D. Peterson | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.5% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Scott P. Callahan | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 90.7% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Sean P. Downes | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 97.1% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Shannon A. Brown | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.8% support |
| Universal Insurance Holdings, Inc. | 2026-06-11 | Election of twelve directors: Stephen J. Donaghy | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Elected, 98.5% support |
| Community Trust Bancorp, Inc. | 2026-04-28 | Proposal to approve the advisory (nonbinding) resolution relating to executive compensation. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 97.2% support |
| Community Trust Bancorp, Inc. | 2026-04-28 | Proposal to ratify and approve the appointment of BDO USA, P.C. as Community Trust Bancorp, Inc.'s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.9% support |
| Vistance Networks, Inc. | 2026-05-07 | Approval of additional shares under the Company's 2019 Long-Term Incentive Plan. | Abstain | FOR — 5 of 6 Brighthouse funds | Against | Passed (calculated), 97.7% support |
| Old Second Bancorp, Inc. | 2026-05-19 | Proposal to approve on a non-binding, advisory basis, the compensation of the Company's named executive officers, as described in the Company's Proxy Statement. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 98.1% support |
| Old Second Bancorp, Inc. | 2026-05-19 | Proposal to ratify the appointment of Plante & Moran, PLLC as the Company's independent registered public accountants for the fiscal year ending December 31, 2026. | Abstain | FOR — 3 of 3 Brighthouse funds | Against | Passed (calculated), 99.4% support |
959 more in the CSV.
Download all 1,459 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 95.8% of this fund’s 4,517 such votes could be given a sector; the other 188 (4.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 995 | 0 | 0.0% |
| Consumer Discretionary | 903 | 0 | 0.0% |
| Technology | 666 | 0 | 0.0% |
| Industrials | 621 | 2 | 0.3% |
| Finance | 588 | 0 | 0.0% |
| Basic Materials | 103 | 0 | 0.0% |
| Utilities | 96 | 0 | 0.0% |
| Energy | 91 | 0 | 0.0% |
| Real Estate | 85 | 0 | 0.0% |
| Miscellaneous | 80 | 0 | 0.0% |
| Telecommunications | 69 | 0 | 0.0% |
| Consumer Staples | 32 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 3,027 | 0 |
| Say-on-Pay | 562 | 2 |
| Audit-related | 531 | 0 |
| Compensation | 186 | 0 |
| Corporate Governance | 102 | 0 |
| Capital Structure | 49 | 0 |
| Extraordinary Transactions | 42 | 0 |
| Shareholder Rights and Defenses | 37 | 0 |
| Environment or Climate | 2 | 0 |
| Human Rights or Human Capital/workforce | 2 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| agilon health, inc. | March 17, 2026 | $4M | 2 | 0 |
| Bloom Energy Corporation | May 21, 2026 | $3M | 8 | 0 |
| Lumentum Holdings Inc. | November 19, 2025 | $2M | 11 | 0 |
| Nextracker Inc. | August 18, 2025 | $2M | 5 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $1M | 5 | 0 |
| Glaukos Corporation | May 28, 2026 | $1M | 4 | 0 |
| Moderna, Inc. | November 12, 2025 | $1M | 2 | 0 |
| Ensign Group, Inc. | May 13, 2026 | $1M | 6 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 21, 2026 | Constellium SE | Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every two years | Against | For |
| May 21, 2026 | Constellium SE | Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every three years | Against | For |
Meetings with a proxy contest or competing nominees (3 in 2025-2026), and how the fund voted the items on its ballot.
4,543 ballot items at 579 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, AVIP BlackRock Advantage Small Cap Growth Portfolio voted at 579 shareholder meetings of 560 companies, on 4,543 ballot items in all. Where management made a recommendation, the fund followed it on 41.4% of the items and voted against it 2 times. Its most frequent area of disagreement was say-on-pay (2 of its votes against management). It voted on 25 shareholder proposals. It voted FOR the board's own proposals less often than Brighthouse's funds as a whole (2.1% against 76.3%). It voted differently from most Brighthouse funds on 1,459 items. 3 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.